Oroszlán, Melinda; Bieri, Michael; Ligeti, Nathalie; Farkas, Anikó; Meier, Bernhard; Marti, Hans-Peter; Mohacsi, Paul (2010). Sirolimus and everolimus reduce albumin endocytosis in proximal tubule cells via an angiotensin II-dependent pathway. Transplant immunology, 23(3), pp. 125-32. Amsterdam: Elsevier 10.1016/j.trim.2010.05.003
Full text not available from this repository. (Request a copy)The proliferation signal inhibitors (PSIs) sirolimus (SRL) and everolimus (ERL) often induce proteinuria due to glomerular but also tubular dysfunction in transplant patients. The beneficial effect of angiotensin converting enzyme inhibitors (ACE-I) and angiotensin II (Ang II) type 1 receptor blockers (ARB) has been reported.
Item Type: |
Journal Article (Original Article) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Cardiovascular Disorders (DHGE) > Clinic of Cardiology 04 Faculty of Medicine > Department of Dermatology, Urology, Rheumatology, Nephrology, Osteoporosis (DURN) > Clinic of Nephrology and Hypertension |
UniBE Contributor: |
Oroszlan, Melinda, Meier, Bernhard, Marti, Hans-Peter, Mohacsi, Paul |
ISSN: |
0966-3274 |
Publisher: |
Elsevier |
Language: |
English |
Submitter: |
Factscience Import |
Date Deposited: |
04 Oct 2013 14:10 |
Last Modified: |
05 Dec 2022 14:01 |
Publisher DOI: |
10.1016/j.trim.2010.05.003 |
PubMed ID: |
20470887 |
Web of Science ID: |
000280210100006 |
URI: |
https://boris.unibe.ch/id/eprint/1582 (FactScience: 203359) |
Actions (login required)
 |
Edit item |